Effects of N-acetyl Cysteine During Primary Percutaneous Coronary Intervention
Status:
Active, not recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the effects of N-acetyl cysteine on major cardiac and
cerebral events in patients undergoing primary percutaneous coronary intervention who have
moderate to high risk for contrast induced nephropathy.
In a sub-group of patients coronary flow reserve will be evaluated.